Jørgen Drejer
Founder at SANA AB
Net worth: 463 424 $ as of 30/04/2024
Network origin in Jørgen Drejer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Trucking | 28 | |
22
| Public Company | Biotechnology | 22 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.
17
| Subsidiary | Biotechnology | 17 |
The Danish Academy of Technical Sciences
13
| College/University | Other Consumer Services | 13 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.
12
| Private Company | Pharmaceuticals: Major | 12 |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.
7
| Extinct | Pharmaceuticals: Major | 7 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
DELTA, Dansk, Elektronik, Lys & Akustik
 DELTA, Dansk, Elektronik, Lys & Akustik Miscellaneous Commercial ServicesCommercial Services DELTA, Dansk, Elektronik, Lys & Akustik offers technical consultancy services in the fields of electronics, microelectronics, software technology, light, optics, acoustics, vibration and sensor systems. The company was founded by P.O. Pedersen in 1941 and is headquartered in Horsholm, Denmark.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer.
4
| Private Company | Medical/Nursing Services | 4 |
Danish National Research Foundation
3
| Private Company | 3 | |
DELTA A/S (Denmark)
 DELTA A/S (Denmark) Miscellaneous Commercial ServicesCommercial Services DELTA A/S is a testing and consulting private company based in Hørsholm, Denmark. DELTA A/S operates as a testing and consulting Danish company. The CEO of the company is Per Hartlev.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Atonomics A/S
 Atonomics A/S Electronic Equipment/InstrumentsElectronic Technology Atonomics A/S provides diagnostic equipment for the biotechnology industries. Its product Atolyzer, is a microscopic biosensor that applies surface acoustic waves in the measurement of low levels of biomarkers in biological samples. The firm develops products for the benefit of health care professionals and patients. The company was founded by Thomas Warthoe, Peter Warthoe and Lars Bangsgaard on October 5, 2000 and is headquartered in Copenhagen, Denmark.
1
| Extinct | Electronic Equipment/Instruments | 1 |
Danish Council for Independent Research
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jørgen Drejer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Founder Corporate Officer/Principal Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| 2CUREX AB | Medical Specialties | Founder Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin | |
| University of Aarhus | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Graduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chairman Chairman Chairman Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
Cheminova A/S
 Cheminova A/S Chemicals: AgriculturalProcess Industries Cheminova A/S manufactures pesticides and other agrochemical products. It offers herbicides, insecticides, fungicides, seed dressings, regulants, grain protectants, and animal health products. The company was founded by Gunnar Andreasen in 1938 and is headquartered in Harboøre, Denma rk. | Chemicals: Agricultural | Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member Chairman Chairman | |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
The Danish National Advanced Technology Foundation
 The Danish National Advanced Technology Foundation Financial ConglomeratesFinance The Danish National Advanced Technology Foundation promotes research and innovation by providing funds. It offers private companies and universities the funds and the framework for developing new and important technologies. The company was founded in 2005 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member Chairman | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Founder Chief Executive Officer | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Sales & Marketing | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Founder | |
| DEMANT A/S | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Founder Founder | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| AURIGA INDUSTRIES A/S | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
| MONSENSO A/S | Internet Software/Services | Founder Chairman | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Tryg Forsikring A/S
 Tryg Forsikring A/S Multi-Line InsuranceFinance Tryg Forsikring AS provides general insurance services. It operates through the following segments: Private, Commercial, Corporate, and Sweden. The Private segment includes the sale of insurances to private individuals. The Commercial segment encompasses the sale of insurances to small and medium sized enterprises. The Corporate segment sells insurances to industrial clients as well as activities related to brokers. The Sweden segment focuses on sale of insurance products to individuals in Sweden. The company was founded in 1971 and is headquartered in Ballerup, Denmark. | Multi-Line Insurance | Director/Board Member Chairman | |
| TRYG A/S | Insurance Brokers/Services | Director/Board Member Chairman | |
Nuevolution A/S
 Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Brown University | College/University | Doctorate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member Director/Board Member | |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Director/Board Member Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member Founder |
Statistics
International
| Denmark | 43 |
| Sweden | 6 |
| United States | 3 |
| France | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 6 |
| Process Industries | 3 |
Operational
| Director/Board Member | 450 |
| Corporate Officer/Principal | 183 |
| Chairman | 147 |
| Chief Executive Officer | 108 |
| Founder | 77 |
Most connected contacts
| Insiders | |
|---|---|
| Søren Lemonius | 39 |
| Kaare Vagner Jensen | 37 |
| Jukka Pekka Pertola | 34 |
| Mette Agger | 30 |
| Joseph deBethizy | 29 |
| Jørgen Hansen | 29 |
| Patrik Olof Dahlén | 28 |
| Claus Tycho Bræstrup | 27 |
| Torbjørn Bjerke | 27 |
| Anker Gunvald Lundemose | 25 |
| Flemming Heise Pedersen | 24 |
| Mats Gunnar Pettersson | 23 |
| Thomas Hofman-Bang | 22 |
| Robert Hoffman | 22 |
| Carl Johan Bertil Sundberg | 21 |
- Stock Market
- Insiders
- Jørgen Drejer
- Company connections
